|
"許駿"的相关文件
显示项目 121-145 / 145 (共6页) << < 1 2 3 4 5 6 > >> 每页显示[10|25|50]项目
國立臺灣大學 |
2005 |
Unexpected Rapid Progression of Metastatic Adenoid Cystic Carcinoma during Treatment with Imatinib Mesylate
|
顏若芳; 鄭永銘; 曾凱元; 許駿; 洪瑞隆; YEN, RUOH-FANG; JENG, YUNG-MING; TZEN, KAI-YUAN; HSU, CHIUN; HONG, RUEY-LONG |
國立臺灣大學 |
2005 |
A Phase Ii Study Using Multi-Fractionation of Paclitaxel and Cisplatin by Twice Weekly Schedule, Plus Weekly 24-Hour Infusion of High-Dose 5- Fluorouacil and Leucovorin (Twice Weekly Tp-Hdfl) in the Treatment of Metastatic or Recurrent Esophageal Cancer: T
|
林家齊; 徐志宏; 葉坤輝; 許駿; 蔡育傑; 鄭安理; LIN, CHIA-CHI; HSU, CHIH-HUNG; YEH, KUN-HUEI; HSU, CHIUN; TSAI, YU-CHIEH; CHENG, ANN-LII |
國立臺灣大學 |
2005 |
Effect of Thalidomide in Hepatocellular Carcinoma: Assessment with Power Doppler Us and Analysis of Circulating Angiogenic Factors
|
許駿; 陳炯年; 謝豐舟; 鄭安理; HSU, CHIUN; CHEN, CHIUNG-NIEN; HSIEH, FON-JOU; CHENG, ANN-LII |
國立臺灣大學 |
2005 |
Survival of Stage Iiib/Iv Non-Small Cell Lung Cancer Patients Who Received Chemotherapy but Did Not Participate in Clinical Trials
|
郭頌鑫; 楊志新; 余忠仁; 許駿; 鄭安理; 楊泮池; KUO, SUNG-HSIN; YANG, CHIH-HSIN; YU, CHONG-JEN; HSU, CHIUN; CHENG, ANN-LII; YANG, PAN-CHYR |
國立臺灣大學 |
2005 |
Phase Ii Study of Weekly Paclitaxel and 24-Hour Infusion of High-Dose 5- Fluorouracil and Leucovorin in the Treatment of Recurrent or Metastatic Gastric Cancer
|
葉坤輝; 盧彥伸; 徐志宏; 林靜芳; 許駿; 郭頌鑫; 鄭安理; YEH, KUN-HUEI; LU, YEN-SHEN; HSU, CHIH-HUNG; LIN, JING-FANG; HSU, CHIUN; KUO, SUNG-HSIN; CHENG, ANN-LII |
國立臺灣大學 |
2005 |
A Phase Ii Trial of Docetaxel, Capecitabine, and Cisplatin as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
|
盧彥伸; 楊志新; 許駿; LU, YEN-SHEN; YANG, CHIH-HSIN; HSU, CHIUN |
國立臺灣大學 |
2005 |
Gefitinib Treatment for Non-Small Cell Lung Cancer-a Study Including Patients with Poor Performance Status
|
蘇文彬; 楊志新; 余忠仁; 楊泮池; 施金元; 許駿; 楊志新; SU, WEN-PIN; YANG, CHIH-HSIN; YU, CHONG-JEN; YANG, PAN-CHYR; SHIH, JIN-YUAN; HSU, CHIUN |
國立臺灣大學 |
2004 |
肝細胞癌藥物治療之研究
|
許駿; Hsu, Chiun |
國立臺灣大學 |
2004 |
Lack of Efficacy of Troglitazone at Clinically Achievable Concentrations, Alone or in Combination with 9-Cis Retinoic Acid or Cytotoxic Agents, for Hepatocellular Carcinoma Cells.
|
沈盈君; 許駿; 陳靜怡; 鄭安理; SHEN, YING-CHUN; HSU, CHIUN; CHEN, JING-YI; CHENG, ANN-LII |
國立臺灣大學 |
2004 |
Recent Advances in Non-Surgical Treatment for Advanced Hepatocellular Carcinoma (Hcc)
|
許駿; 成佳憲; 鄭安理; HSU, CHIUN; CHENG, CHIA-HSIEN; CHENG, ANN-LII |
國立臺灣大學 |
2004 |
Weekly Gemcitabine Plus 24-Hour Infusion of High-Dose 5-Fluorouracil/ Leucovorin for Locally Advanced or Metastatic Carcinoma of the Biliary Tract.
|
許駿; 沈盈君; 楊志新; 葉坤輝; 盧彥伸; 徐志宏; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; YANG, CHIH-HSIN; YEH, KUN-HUEI; LU, YEN-SHEN; HSU, CHIH-HUNG; CHENG, ANN-LII |
國立臺灣大學 |
2004 |
Phase Ii Study of Combination Doxorubicin, Interferon-Alpha, and High- Dose Tamoxifen Treatment for Advanced Hepatocellular Carcinoma
|
盧彥伸; 許駿; 李啟誠; 郭頌鑫; 葉坤輝; 楊志新; 徐志宏; 吳貞瑤; 鄭安理; LU, YEN-SHEN; HSU, CHIUN; LI, CHI-CHENG; KUO, SUNG-HSIN; YEH, KUN-HUEI; YANG, CHIH-HSIN; HSU, CHIH-HUNG; WU, CHEN-YAO; CHENG, ANN-LII |
國立臺灣大學 |
2003 |
比較慢性B型肝炎及C型肝炎引發之肝細胞癌之腫瘤血管生成機轉,及其對於血管生成抑制劑治療反應之差異
|
許駿 |
國立臺灣大學 |
2003 |
Survival-weighted health profile for long-term survivors of acute myelogenous leukemia
|
Hsu, Chiun; Wang, Jung-Der; Hwang, Jing-Shiang; Tien, Hwei-Fang; Chang, Shueh-Mei; Cheng, Ann-Lii; Chen, Yao-Chang; Tang, Jih-Luh; 許駿; 王榮德; 黃景祥; 田蕙芬; 張雪梅; 鄭安理; 陳耀昌; 唐季祿 |
國立臺灣大學 |
2003 |
Long-Term Quality of Life (Qol) of Patients with Hematological Malignancies Who Underwent Hematopoietic Stem Cell Transplantation: Comparison between the Utility and the Profile Approaches
|
許駿; 王榮德; 黃景祥; 姚開屏; 唐季祿; HSU, CHIUN; WANG, JUNG-DER; HWANG, JING-SHIANG; YAO, KAI-PING GRACE; TANG, JIH-LUH |
國立臺灣大學 |
2003 |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma
|
許駿; 陳炯年; 陳立宗; 吳貞瑤; 楊培銘; 賴明陽; 李伯皇; 鄭安理; HSU, CHIUN; CHEN, CHIUNG-NIEN; CHEN, LI-TZONG; WU, CHEN-YAO; YANG, PEI-MING; LAI, MING-YANG; LEE, PO-HUANG; CHENG, ANN-LII |
國立臺灣大學 |
2003 |
Use of Power Doppler Sonography and Circulating Angiogenic Factors to Assess The Potential Antiangiogenic Effect of Thalidomide in Hepatocellular Carcinoma
|
許駿; 陳炯年; 陳立宗; 吳貞瑤; 謝豐舟; 鄭安理; HSU, CHIUN; CHEN, CHIUNG-NIEN; CHEN, LI-TZONG; WU, CHEN-YAO; HSIEH, FON-JOU; CHENG, ANN-LII |
國立臺灣大學 |
2002 |
A Phase Ii Study of Weekly Methotrexate, Cisplatin, and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin (Mp-Hdfl) in Patients with Metastatic and Recurrent Esophageal Cancer-Improving Toxicity Profile by Infusional Schedule and Double Biochem
|
徐志宏; 鄭安理; 許駿; 楊志新; 盧彥伸; 卜慶芳; 葉坤輝; HSU, CHIH-HUNG; CHENG, ANN-LII; HSU, CHIUN; YANG, CHIH-HSIN; LU, YEN-SHEN; BU, CHING-FANG; YEH, KUN-HUEI |
國立臺灣大學 |
2002 |
Survival-Weighted Health Profile for Patients with Hematological Malignancies: Comparison between Patients Who Underwent Bone Marrow (Bm) Vs. Peripheral Blood Stem Cell (Pbsc) Transplantation.
|
許駿; 王榮德; 黃景祥; 田蕙芬; 姚明; 張雪梅; 鄭安理; 陳耀昌; 唐季祿; HSU, CHIUN; WANG, JUNG-DER; HWANG, JING-SHIANG; TIEN, HWEI-FANG; YAO, MING; CHANG, SHUEH-MEI; CHENG, ANN-LII; CHEN, YAO-CHANG; TANG, JIH-LUH |
國立臺灣大學 |
2002 |
Her-2/Neu Overexpression Is Rare in Hepatocellular Carcinoma and Not Predictive of Anti-Her-2/Neu Regulation of Cell Growth and Chemosensitivity
|
許駿; 許輝吉; 鄭安理; HSU, CHIUN; HSU, HEY-CHI; CHENG, ANN-LII |
國立臺灣大學 |
2002 |
Phase Ii Trial Combining Paclitaxel with 24-Hour Infusion Cisplatin for Chemotherapy-Naive Patients with Locally Advanced or Metastatic Breast Carcinoma
|
許駿; 黃俊升; 張金堅; 鄭安理; HSU, CHIUN; HUANG, CHIUN-SHENG; CHANG, KING-JEN; CHENG, ANN-LII |
國立臺灣大學 |
2002 |
Gemcitabine and Cisplatin in a Multimodality Treatment for Locally Advanced Non-Small Cell Lung Cancer
|
楊志新; 李元麒; 雷德; 許駿; 鄭安理; 陳育民; 陸坤泰; 彭瑞鵬; 楊泮池; YANG, CHIH-HSIN; LEE, YUNG-CHIE; LUI, LOUIS TAK; HSU, CHIUN; CHENG, ANN-LII; CHEN, YU-MING; LUH, KWEN-TAY; PENG, JUI-PENG; YANG, PAN-CHYR |
國立臺灣大學 |
2001 |
Comparison of Malt and Non-Malt Primary Large Cell Lymphoma of the Stomach - Does Histologic Evidence of Malt Affect Chemotherapy Response?
|
許駿; 鄭安理; HSU, CHIUN; CHENG, ANN-LII |
國立臺灣大學 |
2000 |
Chemotherapy Alone Versus Surgery Followed by Chemotherapy for Stage I/ Iie Large-Cell Lymphoma of the Stomach
|
劉漢鼎; 許駿; 陳志榮; 江宜平; 陳立宗; 陳耀昌; 鄭安理; LIU, HAN-TING; HSU, CHIUN; CHEN, CHI-LONG; CHIANG, I-PING; CHEN, LI-TZONG; CHEN, YAO-CHANG; CHENG, ANN-LII |
國立臺灣大學 |
1999 |
Allogeneic Stem Cell Transplantation for Patients with High-Risk Myelodysplastic Syndrome
|
許駿; 林敏哲; 唐季祿; 田蕙芬; 王秋華; 陳耀昌; HSU, CHIUN; LIN, MING-TSEH; TANG, JIH-LUH; TIEN, HWEI-FANG; WANG, CHIU-HWA; CHEN, YAO-CHANG |
显示项目 121-145 / 145 (共6页) << < 1 2 3 4 5 6 > >> 每页显示[10|25|50]项目
|